Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDINAVIR vs INEBILIZUMAB-CDON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INDINAVIR vs INEBILIZUMAB-CDON: Safety Overview

Metric INDINAVIR INEBILIZUMAB-CDON
Total FAERS Reports 728 355
Deaths Reported 15 21
Death Rate 2.1% 5.9%
Hospitalizations 114 87
Average Patient Age 45.2 yrs 52.6 yrs
% Female Patients 29.9% 86.8%
FDA Approval Date Apr 19, 2000 N/A
Marketing Status Discontinued Prescription